Outcomes After Stereotactic Body Radiotherapy or Radiofrequency Ablation for Hepatocellular Carcinoma. - Wikidata - wikimedia - TriplyDB

Outcomes After Stereotactic Body Radiotherapy or Radiofrequency Ablation for Hepatocellular Carcinoma.

Outcomes After Stereotactic Body Radiotherapy or Radiofrequency Ablation for Hepatocellular Carcinoma.

http://www.wikidata.org/entity/Q35858275

about

Image-guided high-dose-rate brachytherapy of malignancies in various inner organs - technique, indications, and perspectives Radiotherapy as valid modality for hepatocellular carcinoma with portal vein tumor thrombosis Technical advances in external radiotherapy for hepatocellular carcinoma Radiation therapy for hepatobiliary malignancies.Management of unresectable intrahepatic cholangiocarcinoma: how do we decide among the various liver-directed treatments?Survival and prognostic factors for patients with advanced hepatocellular carcinoma after stereotactic ablative radiotherapy.External beam radiotherapy for unresectable hepatocellular carcinoma, an international multicenter phase I trial, SAKK 77/07 and SASL 26 Treatment of liver cancer of middle and advanced stages using ultrasound-guided percutaneous ethanol injection combined with radiofrequency ablation: A clinical analysis Eastern Canadian Gastrointestinal Cancer Consensus Conference 2016.Individualized Adaptive Stereotactic Body Radiotherapy for Liver Tumors in Patients at High Risk for Liver Damage: A Phase 2 Clinical Trial.Proton beam therapy for hepatocellular carcinoma.State of the ablation nation: a review of ablative therapies for cure in the treatment of hepatocellular carcinoma.Current Standard and Future Perspectives in Non-Surgical Therapy for Hepatocellular Carcinoma.NCCN Guidelines Insights: Hepatobiliary Cancers, Version 1.2017 Radiotherapy for Hepatocellular Carcinoma: New Indications and Directions for Future Study.Stereotactic ablative radiotherapy in the treatment of hepatocellular carcinoma >3 cm.Cost-effectiveness of Stereotactic Body Radiation Therapy versus Radiofrequency Ablation for Hepatocellular Carcinoma: A Markov Modeling Study.Excellent local control and tolerance profile after stereotactic body radiotherapy of advanced hepatocellular carcinoma.Viability of Non-Coplanar VMAT for Liver SBRT as Compared to Coplanar VMAT and Beam Orientation Optimized 4π IMRT.Radiofrequency ablation of hepatocellular carcinoma as bridge therapy to liver transplantation: A 10-year intention-to-treat analysis.Reply to Yang et al and De Bari et al.Advances and Future Directions in the Treatment of Hepatocellular Carcinoma Optimizing global liver function in radiation therapy treatment planning Radiofrequency ablation versus stereotactic body radiotherapy for small hepatocellular carcinoma: a Markov model-based analysis.Can Stereotactic Body Radiotherapy Really Be Considered the Preferred Treatment in Large Hepatocellular Carcinoma?Is Stereotactic Body Radiotherapy Better Than Radiofrequency Ablation for the Treatment of Hepatocellular Carcinoma?Observation of different tumor motion magnitude within liver and estimate of internal motion margins in postoperative patients with hepatocellular carcinoma.Stereotactic Body Radiation Therapy as an Alternative to Transarterial Chemoembolization for Hepatocellular Carcinoma.Breathing-motion-compensated robotic guided stereotactic body radiation therapy : Patterns of failure analysis.Does liver resection/transplantation affect respiratory induced liver motion in patients with hepatocellular carcinoma?Optimal time of tumour response evaluation and effectiveness of hypofractionated proton beam therapy for inoperable or recurrent hepatocellular carcinoma.Consensus on Stereotactic Body Radiation Therapy for Small-Sized Hepatocellular Carcinoma at the 7th Asia-Pacific Primary Liver Cancer Expert Meeting.Strategic Application of Radiotherapy for Hepatocellular Carcinoma.Classification for long-term survival in oligometastatic patients treated with ablative radiotherapy: A multi-institutional pooled analysis.Phase 2 study of stereotactic body radiotherapy and optional transarterial chemoembolization for solitary hepatocellular carcinoma not amenable to resection and radiofrequency ablation.Stereotactic body radiation therapy (SBRT) in patients with hepatocellular carcinoma and oligometastatic liver disease.Stereotactic Body Radiotherapy: Does It Have a Role in Management of Hepatocellular Carcinoma?Long-term outcomes of the 2-week schedule of hypofractionated radiotherapy for recurrent hepatocellular carcinoma Alpha-fetoprotein-producing rectal cancer successfully responded to preoperative chemoradiotherapy: case report Comparison of local tumor control in patients with HCC treated with SBRT or TACE: a propensity score analysis

P2860

Q26738434-70F7AC88-30B8-4DE1-A1B9-547724A4D40C Q26738533-67A81E01-36AD-486D-91FD-01BE21D3DE4D Q28079760-E1AB1FB7-9269-4FA7-8232-F28636B9D854 Q33593244-387DB6DA-A2CB-457C-9125-CC9072F4630A Q33621522-74943FFF-FAE6-44F2-B910-CD99D652D612 Q33699349-AF60176B-C87A-475C-BDDE-53631A05DA91 Q36249520-E8B5DE50-FB0A-45F2-BDB6-11381A3299CD Q36640192-C4A26A7D-695D-4CB4-A686-56C2031CFC27 Q37524976-9057681C-6F8A-4F27-B509-01B00C45FF56 Q38372397-7624A5AB-7E3A-4A92-BE17-C0B9EF9B6E17 Q38616345-83D57650-FB5C-42EB-8FC0-DAD612E24471 Q38661482-32012BB5-C0AB-4800-9057-00829024D2C4 Q38671883-32250F4A-4D94-4B3C-9250-52317A49F2DA Q38801422-6944A698-2C88-44D5-A4A9-3874B31062C1 Q38845317-6D9B61ED-9D8D-4873-8FE2-2AF209B094DB Q38938405-15A2E83A-555D-4131-A716-11AB0E157416 Q39043108-D48D3F5B-F5CC-4B53-8E58-62016C355D9D Q40137729-29FFDE9D-D099-4ED2-92D0-AAAF4B407FF0 Q40285929-6BE26E93-940B-44D5-A193-D08BBA07D737 Q40346354-FC58FF99-5505-4705-B8E4-236BDF2E660B Q41069195-FF4BE2D8-40FE-4A60-9624-F04D7B5A80AE Q41531360-F4334029-0DDE-4045-9E53-D0B30A8DBED2 Q41783193-4AE66FF1-7D5E-4626-9F0D-345869A7717C Q42364566-10C408ED-2898-4B37-AC44-0E3F2510240B Q42395957-F5BA42BD-64F4-4236-8DC5-6B0307956DAB Q42395961-6801039B-ADCD-4A84-972D-11F38F937997 Q47107042-76992A96-B46E-4DA1-A3F1-552D35ED73E8 Q47609170-1A5234DF-28D4-4EB4-B25C-644090CCFA74 Q47650280-23AC3199-8F59-471F-BA76-648DCA0CA582 Q47871042-460B8766-813D-4653-993E-AB90E5A7E340 Q49423522-1E52CE88-F96A-406C-9063-B30D048C3B73 Q49884635-C657CF77-4527-4E45-8B1D-75DB99C19BCF Q50034659-0A566FEC-AEB6-4C7E-9A44-5DB167A441B5 Q52591818-9C4F65EF-C8A2-4AE0-B7E3-72129D9EF29E Q53125871-95F06B2F-54FE-43AB-9F31-4A93D973BACB Q54974781-B0C6A3B7-10B7-47D3-B1D1-0F08A6D8B887 Q57146748-5414A031-D01B-43F2-A447-4F187C461346 Q58112899-63F56C6C-C8F0-4719-A42A-6330774C7801 Q58762057-47683214-EDAD-42C6-9AE6-12C14D5D637A Q58793629-1A91354A-D765-49F8-840C-154884985C9C

P2860

Outcomes After Stereotactic Body Radiotherapy or Radiofrequency Ablation for Hepatocellular Carcinoma.

http://www.wikidata.org/entity/Q35858275

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Outcomes After Stereotactic Bo ...... for Hepatocellular Carcinoma.

@ast

Outcomes After Stereotactic Bo ...... for Hepatocellular Carcinoma.

@en

type

label

Outcomes After Stereotactic Bo ...... for Hepatocellular Carcinoma.

@ast

Outcomes After Stereotactic Bo ...... for Hepatocellular Carcinoma.

@en

prefLabel

Outcomes After Stereotactic Bo ...... for Hepatocellular Carcinoma.

@ast

Outcomes After Stereotactic Bo ...... for Hepatocellular Carcinoma.

@en

P1433

Q35858275-0AF9B05E-F5EF-4635-BFA1-C22AC8B50F34

P1476

Q35858275-061DBD95-CE30-4296-BF24-435E681DEF8F

P2093

Q35858275-03D8976C-012C-494B-9767-FBA86418938E

Q35858275-439A485B-1FE6-40AD-8256-32E6EA5924F9

Q35858275-4F5FE7C9-9137-4A38-AF39-ADEF300EEBD8

Q35858275-57D13A9F-E1BC-4752-A5CC-47AE4EF1E6EE

Q35858275-8690DFD2-B765-4D7C-BEE7-B977F8CEEA28

Q35858275-96D48EC1-DEB2-4573-B2D0-4DDD3C1D5ACD

Q35858275-BC0719CB-CBA9-4301-A5FB-39F6075A28D6

Q35858275-C1928B31-A66D-44F5-8A33-12E07F6E7606

P2860

Q35858275-04DA20B8-B597-4F21-80B1-854B95996ABD

Q35858275-1D2BD004-F4DB-457D-9F9E-EB2CFE215A06

Q35858275-1E5EE671-26EE-4F35-B739-D169B61016CF

Q35858275-23AF835B-FDB6-46F3-86A8-6CBA06AC6532

Q35858275-2C1306DA-1F00-46E0-B13B-6EFFFCA30573

Q35858275-2D8F5435-FC90-4EF1-A1DD-BC27BBFCE855

Q35858275-366613EF-DBAE-42E8-8A32-683259C2F35A

Q35858275-38D75973-A77C-498C-9360-B32B10462211

Q35858275-3FF4FDEE-C4D7-4237-A078-2171E070497C

Q35858275-41C95471-D8BC-4FA5-B57E-DA91284491F0

P304

Q35858275-E84A88BE-06E4-4B04-9EF1-29CD5135ACDE

P31

Q35858275-2C28B01F-3586-47C6-AE45-3790904DB057

P356

Q35858275-DC540942-7E71-4251-8075-7E9A47C768A6

P407

Q35858275-0F378B5B-F24F-4C91-9242-2E02BCD3C4F1

P433

Q35858275-C729B16D-4EC9-4103-B2F2-4588CCB75670

P478

Q35858275-E6B63D94-87C9-432A-AE1A-F649F7156CF4

P577

Q35858275-2D3051B7-EE7B-4C9E-8BB3-F481DED78B3F

P698

Q35858275-3B246E5B-4DCD-46CA-88D7-3201583CE49B

P921

Q35858275-944460BE-3C44-431B-9F98-6765268B7FED

P932

Q35858275-279DD14A-F16E-4BC9-93AE-546E0ECDE57D

P356

JCO.2015.61.4925

P1433

Journal of Clinical Oncology

P1476

Outcomes After Stereotactic Bo ...... for Hepatocellular Carcinoma.

@en

P2093

Daniel R Wahl

http://www.w3.org/2001/XMLSchema#string

Elaine M Caoili

http://www.w3.org/2001/XMLSchema#string

Erqi L Pollom

http://www.w3.org/2001/XMLSchema#string

Mary Feng

http://www.w3.org/2001/XMLSchema#string

Matthew H Stenmark

http://www.w3.org/2001/XMLSchema#string

Matthew J Schipper

http://www.w3.org/2001/XMLSchema#string

Theodore S Lawrence

http://www.w3.org/2001/XMLSchema#string

Yebin Tao

http://www.w3.org/2001/XMLSchema#string

P2860

A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma

Surgical resection of high-risk hepatocellular carcinoma: patient selection, preoperative considerations, and operative technique

Cancer statistics, 2014

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

American Society of Clinical Oncology 2009 clinical evidence review on radiofrequency ablation of hepatic metastases from colorectal cancer.

Long-term effect of stereotactic body radiation therapy for primary hepatocellular carcinoma ineligible for local ablation therapy or surgical resection. Stereotactic radiotherapy for liver cancer.

Causal effects in clinical and epidemiological studies via potential outcomes: concepts and analytical approaches.

Estimating the world cancer burden: Globocan 2000.

Radiofrequency ablation of small hepatocellular carcinoma in cirrhotic patients awaiting liver transplantation: a prospective study.

Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice?

P304

452-459

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2015.61.4925

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

34

http://www.w3.org/2001/XMLSchema#string

P577

2015-11-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26628466

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy

P932

4872011

http://www.w3.org/2001/XMLSchema#string